Good afternoon and thank you for joining Lifecore's fiscal 2025 third quarter earnings call. During the call, all participants will be in a listen-only mode. Now, I would like to turn the call over to ...

Good afternoon, and thank you for joining Lifecore's Fiscal 2025 Third Quarter Earnings Call. During the call, all participants will be in a listen-only mode. Now I would like to turn the call ...

Adjusted EBITDA Guidance: Expected to be in the range of $19 million to $21 million for FY2025. Lifecore Biomedical Inc (NASDAQ:LFCR) signed multiple new agreements with both new and existing ...

Backs FY25 adjusted EBITDA view $19M-$21M. The company said, “For the full fiscal year 2025, the company is reiterating its financial guidance and expects revenue to be approximately $126.5 to $ ...

Lifecore Biomedical (LFCR) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.05 per share a year ago. These ...

CHASKA, Minn. (AP) — CHASKA, Minn. (AP) — Lifecore Biomedical, Inc. (LFCR) on Thursday reported a loss of $14.8 million in its fiscal third quarter. The Chaska, Minnesota-based company said it ...